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Open access under CC BY-NDysphagia after stroke is associated with mortality and increased pulmonary
complications. Swallowing therapies may decrease pulmonary complications
and improve patients’ quality of life after stroke. This study used clinical swal-
lowing assessments and videofluoroscopy (VFS) to assess the functional recovery
of acute stroke patients with dysphagia after different swallowing therapies. We
enrolled 29 acute stroke patients with dysphagia and randomly divided them into
3 therapy groups: traditional swallowing (TS), oropharyngeal neuromuscular
electrical stimulation (NMES), and combined NMES/TS. All patients were as-
sessed using the clinical functional oral intake scale (FOIS), 8-point penetra-
tion–aspiration scale (PAS), and functional dysphagia scale (FDS) of VFS before
and after treatment. There were no differences in the clinical parameters and
swallowing results of the FOIS and VFS before swallowing treatment among
the 3 groups (P . .05). TS therapy and combined therapy both had significant
swallowing improvement after therapy according to the FOIS and 8-point PAS
(P , .05). When comparing the results of the VFS among the 3 groups, we found
significant improvements in patients eating cookies and thick liquid after com-
bined NMES/TS therapy (P , .05). In acute stroke patients with dysphagia, com-
bined NMES/TS therapy is the most effective swallowing therapy in taking solid
diets and thick liquids. Key Words: Dysphagia—stroke—neuromuscular
electrical stimulation—swallowing therapy—videofluoroscopy.
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Dysphagia is one of the most common morbidities
after stroke, with a reported incidence of 29%-81%.1-4
Poststroke dysphagia increases the risk for dehydration,
malnutrition, pulmonary complications, and mortality,
all of which lead to a poor prognosis.1,2 Stroke-
associated pneumonia is associated with risk factors of
dysphagia, National Institute of Health Stroke Scale
(NIHSS) greater than or equal to 10, nonlacunar basal
ganglia infarction, and any other infection present on
admission.5 For patients with poststroke dysphagia,
aspiration pneumonia occurs in 43%-50% of patients dur-
ing the first year, with a mortality of up to 45%.6,7
Additionally, it is associated with increased long-term in-
stitutionalization.8 Some patients with severe dysphagia
require a percutaneous feeding tube for nonoral feeding
to sustain adequate nutrition and/or water intake.9 How-
ever percutaneous feeding tube such as nasogatric tubeember-December), 2014: pp 2547-2553 2547
K.-L. HUANG ET AL.2548provided limited protection against aspiration-associated
pneumonia in poststroke patients with dysphagia.10
The enteral feeding tubes also cause nasopharyngeal
discomfort, impairs the patients’ body image, and
affects their quality of life.11 Therefore, early diagnosis
and intervention for poststroke dysphagia is important
and recommended to prevent stroke-associated
pneumonia.12,13
There are several practical methods for decreasing
complications associated with dysphagia, including
postural adjustments, viscosity changes to food and
liquids, oropharyngeal exercises, swallowing maneuvers,
thermal stimulation, and enteral feeding, to manage
swallowing dysfunction.9,14-20 Traditional swallowing
(TS) therapy involves compensation strategies, such as
postural adjustment or diet modification, strengthening
weak oropharyngeal musculature through oral exercise,
swallowing maneuvers for the augment impaired
aspects of oropharyngeal swallowing, and heightening
sensory input through thermal–tactile stimulation. Severe
poststroke dysphagia is more likely to develop aspiration
pneumonia or other potentially complications during
prolonged treatment. However, effective swallowing
therapies are limited for stoke patients with severe
dysphagia, which requires long-term treatment.14
Recently, neuromuscular electrical stimulation
(NMES) has become a possible intervention for re-
storing swallowing function. The VitalStim (Chatta-
nooga Group, Hixson, TN) therapy is a type of
transcutaneous NMES, which was approved by the
Food and Drug Administration in 2001 for treatment
of dysphagia. This therapy bypasses the injured central
swallowing circuitries such as stroke and delivers an
electrical current via electrodes that are placed on the
neck muscles to create a contraction of the swallowing
muscles. NMES may create more laryngeal elevation
and increase the strength of the associated muscles,
which leads to better swallowing motion in dysphagic
patients.21-28 Bulow et al29 reported positive therapy ef-
fects for both NMES and TS therapy combined on more
than 3 months hemispheric stroke patients with oral
and pharyngeal dysfunction. Kushner et al30 presented
that NMES with traditional dysphagia therapy/pro-
gressive resistance training is significantly more effec-
tive than traditional dysphagia therapy/progressive
resistance training only for reducing tube-dependent
dysphagia in acute stroke patient. However, there is
still a lack of more objective evidence about the efficacy
of NMES for treating poststroke dysphagia at acute
phase.
We aimed to evaluate the functional recovery in acute
stroke patients with orophyaryngeal dysphagia after TS,
oropharyngeal NMES, and combined NMES/TS, by us-
ing clinical swallowing assessments and objective video-
fluoroscopy (VFS).Materials and Methods
Participants
Between January 2011 and July 2013, we enrolled 29
acute stroke patients with dysphagia (20 men, 9 women)
who were admitted to a rehabilitation unit of the Chang
Gung Memorial Hospital-Kaohsiung Medical Center in
Taiwan. All the patients’ strokes occurred less than
3 months before enrollment (mean, 22.4 days; range,
5-50 days). The strokes were diagnosed by neurologists
according to the clinical neurologic deficits relating to
their brain damage and the findings on brain computed
tomography or magnetic resonance imaging scans. Their
swallowing disorders were impressed by physiatrists tak-
ing the history of choking or cough during swallowing or
wet voice after conducting a 100-mL water test. Further-
more, a formal swallowing condition was assessed by
1 speech–language therapist.
The inclusion criteria were recent cerebral hemispheric
stroke with swallowing difficulty with functional oral
intake scale (FOIS), which was equal to or less than level
4 while admission to the rehabilitation unit. The exclusion
criteria were as follows: (1) impaired communication abil-
ity due to cognitive deficit, aphasia, or serious psycho-
logic disorders; (2) other systemic neurologic disorders
leading to swallowing difficulty; (3) swallowing disorders
caused by structural lesions, such as an oropharyngeal
tumor or extensive surgery or radiotherapy of the head
and neck region; (4) use of an electrically sensitive
biomedical device (eg, cardiac pacemaker); and (5) pneu-
monia or acute medical conditions at the time of enroll-
ment. The study was reviewed by the institutional
ethics committee at our hospital, and after understanding
of all procedures in this study, informed consent was
obtained from each patient.
Procedures
Clinical parameters, including age, gender, stroke type,
stroke location, duration since stroke onset, the Mini-
Mental State Examination (MMSE), and the National
Institute of Health Stroke Scale (NIHSS), were recorded
when the participants were admitted to our rehabilitation
unit. We randomly divided the patients into 3 groups.
There were 11 patients in the TS group, 8 patients in the
NMES group, and 10 patients in the combined NMES/
TS group.
In the TS group, the therapies included oral exercise,
compensatory techniques (eg, chin tuck, head tilt, and
head rotation), faucial thermal–tactile stimulation, and
swallowing therapeuticmaneuvers (eg, supraglottic swal-
lowing, effortful swallowing, and the Mendelsohn ma-
neuver). These dysphagia therapies are commonly used
in rehabilitation departments. The TS therapies were per-
formed by 1 qualified and experienced speech–language
therapist. The choice of specific and compensatory
OUTCOME IN STROKE PATIENTS AFTER SWALLOWING THERAPY 2549techniques and swallowing maneuvers was based on the
findings of VFS and the clinical evaluation of swallowing.
This groupof patientswas treated 3 times perweek (60mi-
nutes per treatment), and 10 sessions were performed for
each patient.
In the NMES group, we used the VitalStim therapeutic
device, which consists of a dual channel with 2 bipolar
electrodes for each channel. The parameters of electrical
stimulator are a pulse width of 700 ms, frequency of
80 Hz, and wave amplitude of 0-25 mA. A licensed phys-
iatrist with 10 years of clinical experience and certified
training in using the VitalStim electrical stimulator
administered the NMES. Each patient’s anterior neck
skin was cleaned using an alcohol swab to remove sub-
stances that might interfere with the electrode contact,
and the 2 sets of electrodes were placed on the patients’
anterior neck. The placement of the dual-channel elec-
trodes was located in 1 vertical line with channel 1 above
the thyroid notch and channel 2 below the thyroid notch.
The wave amplitude of the treatment was set according to
the patient’s tolerance level, and it gradually increased in
a stepwise increment of .5 mA from 0mA until the patient
felt a tingling sensation on the neck and a muscle contrac-
tion. The tolerance wave amplitude was different among
individuals. The current intensity of the electrical stimu-
lation was determined and fixed during the treatment
session. Patients were not instructed to perform any
oropharyngeal exercises or swallowing training during
NMES treatment. These patients were treated 3 times
per week (60 minutes per session), and 10 sessions of
NMES were performed per patient.
In the combined NMES/TS group, another licensed
physiatrist with experienced and certified training in using
theVitalStimdevice administered the therapy. Thesepartic-
ipants acceptedcombinedTS therapies fromthesamephys-
iatrist while receiving NMES therapy. The treatment
occurred 3 times per week (60 minutes per treatment),
and each patient had 10 sessions.Outcome Measurement
Three quantifiable methods were used to evaluate the
swallowing function before and after treatment. The
FOIS was reported by Crary et al31 for assessing the oral
intake of food and liquid in stroke patients. The FOIS is
a statistically validated scale that reflects the functional
oral intake of poststroke patients with dysphagia.31 An
ordinal series of 7 swallowing function levels was used
(1-7). The level ranged from nothing by mouth (level 1)
to total oral diet with no restriction (level 7). One
speech–language therapist who was blinded to all proce-
dures evaluated the FOIS for each patient before and after
swallowing treatments.
The VFS is a standard tool for observation and identifi-
cation of swallowing abnormalities. The 8-point penetra-
tion–aspiration scale (PAS) and functional dysphagiascale (FDS) based on VFS provided a quantitative and
objective measurement for swallowing disorders.32,33
The 8-point PAS describes the severity of respiration
compromise and is a validated and reliable index of aspi-
ration.32,34 Penetration was defined as any material
entering the laryngeal vestibule but remaining at or
above the vocal folds. Aspiration was defined as any
material entering the larynx below the vocal folds. In
the 8-point PAS, the scores ranged from normal swallow-
ing without material entering the airway (score 1) to se-
vere airway compromise with material entering the
airway and passing below the vocal folds (score 8). The
11-item FDS reported by Han et al33 in 2001 is a sensitive
and specific method for quantifying swallowing function
in stroke patient. The FDS is composed of 11 items that
quantitatively measure oral function (lip closure, bolus
formation, residual in oral cavity, and oral transit time)
and pharyngeal function (triggering of pharyngeal swal-
lowing, laryngeal elevation and epiglottis closure, nasal
penetration, triggering, residue in valleculae and pyri-
form sinus, pharyngeal coating, and pharyngeal transit
time) during VFS. A total 100 points was scored according
to the findings of VFS. The lower the FDS score, the better
swallowing function. The FDS was measured during 4 di-
ets (soft diet, cookies, thick liquid, and thin liquid). Both
the 8-point PAS and FDS were interpreted and scored
before and after each therapy by another well-
experienced speech–language therapist who was also
blinded to all 3 interventions.
Data Analysis
SPSS software, version 12.0 (SPSS, Chicago, IL) was
used to analyze all collected data. The Kruskal–Wallis
test was used to compare differences in age, MMSE,
NIHSS among the TS, NMES, and combined NMES/TS
groups at admission. The differences in gender, stroke
type, and stroke location among the TS, NMES, and com-
bined NMES/TS groups at admission were calculated us-
ing c2 test. The FOIS, FDS, and 8-point PAS scales were
assessed among the 3 groups before and after treatment
and were compared using the Kruskal–Wallis test. The
statistical significance was set as P , .05.
Results
Twenty-nine acute stroke patients with dysphagia were
included in this study. All clinical parameters are shown
in Table 1. Eleven patients were in the TS group (5 women
and 6 men; median age, 67.0 years), 8 patients were in the
NMES group (3 women and 5 men; median age,
64.5 years), and 10 patients were in the combined
NMES/TS group (1 woman and 9 men; median age,
68.9 years). There were no significant differences in age,
gender, stroke type, NIHSS, MMSE, and stroke duration
among the 3 groups. In the TS group, there were 6 pa-
tients (55%) without oral intake (FOIS, 1) and 5 patients
Table 1. Comparison of clinical characteristics in stroke patients among the 3 groups
Characteristics
TS group,
N 5 11
NMES group,
N 5 8
Combined
NMES/TS group,
N 5 10 P value
Age, y, median (IQR) 67.0 (10.1) 64.5 (14.4) 68.9 (9.8) .77
Female/male, n 5/6 3/5 1/9 .25
Stroke type, n (%)
Infarction 9 (81.8) 6 (75.0) 9 (90) .75
Hemorrhage 2 (18.2) 2 (25.0) 1 (10)
Hemiplegic side, n (%)
Left 6 (54.5) 3 (37.5) 6 (60) .30
Right 5 (45.5) 4 (50) 4 (40)
Bilateral 1 (12.5)
MMSE, median (IQR) 17.9 (6.4) 23.4 (3.7) 22.6 (5.0) .10
NIHSS, median (IQR) 10.7 (5.1) 9.0 (2.8) 7.6 (3.9) .30
Duration, median (IQR) 25.2 (16.0) 16.6 (6.6) 23.5 (13.9) .61
Abbreviations: IQR, interquartile range; MMSE, Mini-Mental State Examination; NIHSS, National Institute of Health Stroke Scale; NMES,
neuromuscular electrical stimulation; TS, traditional swallowing.
Chi-square test for gender, stroke type, and hemiplegic side and Kruskal–Wallis test for age, MMSE, and NIHSS.
K.-L. HUANG ET AL.2550(45%) with minimal to total oral intake (FOIS, 2-4). Three
patients (38%) with FOIS 1 and 5 patients (62%) with FOIS
2-4 were in the NMES group. Five patients (50%) with
FOIS 1 and 5 patients (50%) with FOIS 2-4 were in the
combined NMES/TS group. No significant difference
was noted in FOIS subgroup among these 3 groups.
The median FDS during VFS before therapy while on a
soft diet, cookies, and thick and thin liquid were 21.1,
19.2, 26, and 18.9 in the TS group, 11.4, 17.8, 18.9, and
12.4 in the NMES group, and 25.4, 30, 32.6, and 22.3 in
the combined NMES/TS group, respectively (Table 2).
The median 8-point PAS during VFS in the TS, NMES,
and combined NMES/TS groups were 3.8, 3.0, and 3.5,
respectively. The median FOIS in the TS, NMES, and com-
binedNMES/TSgroupswere 1.6, 2.3, and1.8, respectively.
There were no statistically significant differences in the
swallowing evaluations, including the median FOIS, 8-
point PAS, and FDS during VFS, among the 3 groups
before therapy. The median FDS scales while on a soft
diet, cookies, and thick and thin liquid were 21.1, 19.2,
26, and 18.9 before treatment and 15.7, 24.8, 23.4, and
16.2 after treatment in the TS group, respectively. The me-
dian FDS scales in the 4 kinds of diet were 11.4, 17.8, 18.9,
and 12.4 before treatment and 18.3, 22.5, 22.6, and 11.9 after
treatment in the NMES group, respectively. The median
FDS scales while on a soft diet, cookies, and thick and
thin liquid were 25.4, 30, 32.6, and 22.3 before treatment
and 16.4, 10.6, 24.7, and 16.8 after treatment in the com-
bined NMES/TS group, respectively. In the TS group,
the median 8-point PAS scales were 3.8 and 2.4, and the
median FOIS scales were 1.6 and 4.6 before and after treat-
ment, respectively. In theNMESgroup, themedian 8-point
PASwere3.0 and1.8, and themedianFOISwere 2.3 and4.9
before and after therapy, respectively. In the combinedNMES/TS group, the median 8-point PAS were 3.5 and
2.5, and the median FOIS were 1.8 and 5.5 before and after
therapy, respectively. There were significant differences in
FOIS before and after therapy in all 3 groups (P , .05).
Therewere significant differences in thePASbefore and af-
ter therapy in TS and combined NMES/TS groups (P ,
.05). Significant differences were found between the me-
dian FDS before and after therapy while on a soft diet in
the combined NMES/TS group (P5 .01).
In Table 3, the change of FDS during VFS after therapy
while on a soft diet, cookies, and thick and thin liquid
were 25.4, 7.6, 22.6, and 22.7 in the TS group, 6.9, 4.8,
3.8, and 2.5 in the NMES group, and 29.0, 216.3, 27.9,
and 25.5 in the combined NMES/TS group, respectively.
Significant differences were found in the changes of FDS
while on a cookie (P 5 .03) and thick liquid (P 5 .04) after
treatment among the 3 groups. There were no significant
differences in the changes of FDS while on a soft diet and
thin liquid after therapy among the 3 groups (P..05). The
changes of the 8-point PAS after intervention were 21.5,
21.3, and 21.0 in the TS, NMES, and combined NMES/
TS groups, respectively. The changes of the FOIS were
3.0, 2.6, and 3.7 in the TS, NMES, and combined
NMES/TS groups, respectively. No significant differences
were found in the changes of the 8-point PAS and FOIS
among the 3 groups (P . .05).Discussion
We are the first in this field to investigate the effect
of NMES, TS therapy, and combined NMES and TS ther-
apy in acute stroke with oropharyngeal dysphagia by
both FOIS and VFS with 8-point PAS and FDS. The results
in this study showed that TS, NMES, and combined
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OUTCOME IN STROKE PATIENTS AFTER SWALLOWING THERAPY 2551NMES/TS therapy had a significant improvement on the
clinical FOIS score and TS, and combined NMES/TS ther-
apy had a significant improvement on the 8-point PAS
during VFS. However, no statistically significant differ-
ences were found among these 3 therapies. In the
NMES therapy, we also found an improvement tendency
after treatment on 8-point PAS, but it was not statistically
significant. The study indicated that all 3 treatments
might provide some positive therapeutic effects for acute
stroke patients with dysphagia. The results were consis-
tent with previous studies in chronic stroke. Bulow
et al29 reported statistically significant positive effects
for both NMES and TS therapy in chronic stroke patients
with dysphagia, but there was no statistically significant
difference in therapy effect between the groups.
We demonstrated that a combined NMES/TS therapy
could result in better swallowing performance in FDS
scores than NMES or TS therapy alone while on a cookies
and thick liquid during VFS. In the combined therapy
group, we also found a tendency for the FDS to improve
while on soft diet or thin liquid, but the difference before
and after therapy was not statistically significant. This
result is similar to that of previous studies. Lim et al35 re-
ported that NMES combined with thermal–tactile stimu-
lation is a better treatment for patients with swallowing
disorders after stroke than thermal-tactile stimulation
alone. Kushner et al30 found significant improvement in
FOIS in the NMES group with traditional dysphagia ther-
apy/progressive resistance training; therefore, they sug-
gest that this combined therapy is more effective than
traditional dysphagia therapy/progressive resistance
training only for reducing tube-dependent dysphagia in
acute stroke patients. The application of NMES for
dysphagia associated with oropharyngeal dysfunction is
for improving sensation input of oropharyngeal cavity,
facilitating or restoring the oral or pharyngeal motor
function, and achieving adequate laryngeal elevation.
Therefore, concurrent NMES could further augment or
enhance the contraction of paralyzed oropharyngeal mus-
cles with volitional control. Although the TS therapy is a
mainstay for the management of dysphagia after stroke
by strengthening the weakened oropharyngeal muscles
under voluntary oral or swallowing exercise, these find-
ings supported that NMES could be used as an alternative
therapy for acute stroke patients with dysphagia.
We consider that NMES can be an adjunctive therapy to
the general swallowing therapy. First, with moderate-to-
severe dysphagia, there is little or no muscle contraction
of oropharyngeal muscles under voluntary swallowing ac-
tion. The NMES can avoid the disuse of muscle dystrophy
and strengthen contraction of paralyzed oropharyngeal
muscles. Second, the order of the muscle recruitment of
voluntarymuscle contraction and that of electrical stimula-
tion are different. During normal muscle contraction, the
type I muscle fibers are recruited first and followed by the
recruitment of type II muscle fibers. The recruitment of
Table 3. Change of videofluoroscopy and FOIS results in TS, NMES, and combined NMES/TS groups after therapy
Group TS group, N 5 11 NMES group, N 5 8
Combined NMES/TS group,
N 5 10 P value
FDS
Soft diet, median (IQR) 25.4 (11.3) 6.9 (13.4) 29.0 (10.4) .43
Cookie, median (IQR) 7.6 (11.9) 4.8 (12.6) 216.3 (18.4) .03*
Thick liquid, median (IQR) 22.6 (6.8) 3.8 (9.5) 27.9 (11.2) .04*
Thin liquid, median (IQR) 22.7 (10.3) 2.5 (13.9) 25.5 (7.7) .31
8-point PAS, median (IQR) 21.5 (2.0) 21.3 (1.6) 21.0 (1.6) .87
FOIS, median (IQR) 3.0 (1.4) 2.6 (1.5) 3.7 (1.6) .31
Abbreviations: IQR, interquartile range; FDS, functional dysphagia scale; FOIS, functional oral intake scale; NMES, neuromuscular electrical
stimulation; PAS, penetration–aspiration scale; TS, traditional swallowing.
Kruskal–Wallis test for FDS, 8-point PAS, and FOIS.
*P , .05.
K.-L. HUANG ET AL.2552NMES, reverse of normal voluntary recruitment, involves
type II fibers first followed by slow type I fibers.25,36 The
synchronous recruitment of both types I and II muscle
fibers during combined therapy can generate larger
swallowing muscle force and enhance the therapeutic
effect than NMES or TS exercise alone in dysphagia
treatment. Third, the electrical stimulation combined with
swallowing task training and exercise can increase
swallowing excitability and facilitate motor learning. Park
et al37 reported that effortful swallowing coupledwith elec-
trical stimulation increased the degree of hyoid elevation in
healthyvolunteers.Ludlowetal38observed thathyoidbone
depression occurred with stimulation at rest, and stimula-
tion may have acted to resist the patient’s hyoid elevation
during swallowing. Fourth, the NMES can heighten the
pharyngeal sensory feedback pathway and stimulate
pharyngeal cortical reorganization. Oh et al21 reported
that the swallowing function improvement after electrical
stimulation is correlated with cortical reorganization
measured by corticobulbar output maps, which suggests
that multiple sessions of electrical stimulation applied to
the neckmuscles improve swallowing function via amech-
anism involving long-term cortical reorganization. Howev-
er, the exact mechanism of NMES remains unclear. Further
study is needed to investigate the possible cortical mecha-
nism of NMES on poststroke dysphagic patients.
The following are the several limitations to our study:
(1) we collected a small patient group limited to 1 rehabil-
itation unit in 1 medical center in Taiwan, which may
impede smaller significant differences among groups;
(2) because of an ethical issue, we did not have stroke pa-
tients with dysphagia receive any treatment in a control
group to exclude the effect of a spontaneous recovery of
a swallowing deficit; (3) there was no standard NMES
therapy protocol for the current intensity, frequency, the
duration of the intervention; and (4) there was a lack of
long-term follow-up to assess the swallowing function re-
covery after completing the 3-week therapy.In summary, TS therapy and combined therapy both
have therapeutic effects on improving the swallowing
function based on the clinical FOIS and 8-point PAS dur-
ing VFS in acute stroke patients with dysphagia. Howev-
er, among the 3 therapies, the combined NMES with TS
therapy may result in more positive effects, because it
showed a significant improvement in FDS when the pa-
tients were on a solid diet and thick liquid during VFS.
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